April 4, 2008 Part B Medicare Bulletin
Posted April 4, 2008
Table of Contents
- 2007 Update of HCPCS Codes and Payments for Ambulatory Surgical Centers (ASCs)
- Additional Payable Healthcare Common Procedure Coding System (HCPCS) “C” Drug Codes in Ambulatory Surgical Centers (ASCs)
- Ambulance Providers
- Ambulatory Surgical Center (ASC) Claims Processing Manual Clarification
- Attention Part B Medicare Providers: Modifier Finder Tool Now Available on the CIGNA Government Services Web site!
- Change in the Amount in Controversy Requirement for Administrative Law Judge Hearings and Federal District Court Appeals
- Clarification of Bone Mass Measurement (BMM) Billing Requirements Issued in CR 5521
- Clarification Regarding the Coordination of Benefits Agreement (COBA) Medigap Claim-based Crossover Process
- Clarification to CR 5744 - Payment Allowance Update for the Influenza Virus Vaccine CPT 90660 and further instruction regarding the Pneumococcal Vaccine Current Procedural Terminology (CPT) 90669
- Clinical Lab: New Automated Test for the Automated Multi-channel Chemistry Code (AMCC) Panel Payment Algorithm
- Emergency - Legislative Change Affecting the 2008 Medicare Physician Fee Schedule (MPFS), and Extension of the 2008 Participation Open Enrollment Period
- Emergency Update to the 2008 Medicare Physician Fee Schedule Database (MPFSDB)
- Erythropoiesis Stimulating Agents (ESAs) in Cancer and Related Neoplastic Conditions
- Extension of the Dates of Service Eligible for the Physician Scarcity Area (PSA) Bonus Payment
- Health Care Provider Taxonomy Code Set
- Implementation of the Medicare Clinical Laboratory Services Competitive Bidding Demonstration
- Manualization of Payment for Outpatient End Stage Renal Disease (ESRD) Related Services
- Medicare Fee for Service Legacy Provider IDs Prohibited on Form CMS-1500 Claims after NPI Required Date
- Medicare, Medicaid and State Children’s Health Insurance Program (SCHIP) Extension Act of 2007 (MMSEA) Changes to Independent Laboratory Billing for the Technical Component (TC) of Physician Pathology Services
- Medicare’s Implementation of the National Provider Identifier (NPI): The Second in the Series of Special Edition MLN Matters Articles on NPI-Related Activities
- New Medicare Learning Network (MLN) Products are now available on the topic of Individuals Authorized Access to CMS Computer Services - Provider Community (IACS-PC)
- Part B Drug Competitive Acquisition Program (CAP) Quarterly Drug List Update
- Payment for Hospital Observation Services (Codes 99217 - 99220) and Observation or Inpatient Care Services (Including Admission and Discharge Services - Codes 99234 - 99236)
- Payment for Initial Hospital Care Services (Codes 99221 – 99223) and Observation or Inpatient Care Services (Including Admission and Discharge Services) (Codes 99234 – 99236)
- Process for Amending the List of Compendia for Determination of Medically-Accepted Indications for Off-Label Uses of Drugs and Biologicals in an Anti-Cancer Chemotherapeutic Regimen
- Quarterly Update to Correct Coding Initiative (CCI) Edits, Version 14.1, Effective April 1, 2008
- Reporting of Hematocrit or Hemoglobin Levels on All Claims for the Administration of Erythropoiesis Stimulating Agents (ESAs), Implementation of New Modifiers for Non-ESRD ESA Indications, and Reporting of Hematocrit or Hemoglobin Levels on all Non-ESRD, Non-ESA Claims Requesting Payment for Anti-Anemia Drugs
- Revision to Certification for Hospital Services Covered by the Supplementary Medical Insurance Program as it pertains to Ambulance Services
- Revision to Instructions Relating to Compliance Standards for Independent Diagnostic Testing Facilities (IDTFs)
- Smoking and Tobacco Use Cessation Counseling Billing Code Update to Medicare
- Subsequent Hospital Visits and Hospital Discharge Day Management Services (Codes 99231 - 99239)
- Summary of Policies in the 2008 Medicare Physician Fee Schedule (MPFS) and the Telehealth Originating Site Facility Fee Payment Amount
- Systems Changes for Prescription Order Numbers for the Competitive Acquisition Program (CAP) for Part B Drugs and Biologicals
- Teaching Physician Requirements for End Stage Renal Disease Monthly Capitation Payment (ESRD MCP)
- Upcoming Critical Dates for Medicare's Fee-for-Service (FFS) Implementation of the National Provider Edentifier (NPI)
- Use of Healthcare Common Procedure Coding System (HCPCS) V2787 When Billing Approved Astigmatism-Correcting Intraocular Lens (A-C IOLs) in Ambulatory Surgery Centers (ASCs), Physician Offices, and Hospital Outpatient Departments (HOPDs)
2007 Update of HCPCS Codes and Payments for Ambulatory Surgical Centers (ASCs)
Do you have your NPI? National Provider Identifiers (NPIs) will be required on claims sent on or after May 23, 2007. Every health care provider needs to get an NPI. Learn more about the NPI and how to apply for an NPI by visiting http://www.cms.hhs.gov/NationalProvIdentStand/ on the CMS Web site.
Note: This article was revised on January 24, 2008, to add a reference to SE0742. SE0742 announced that CMS was implementing significant revisions to the payment system for ASC services beginning with services rendered on or after January 1, 2008. SE0742 may be found at http://www.cms.hhs.gov/MLNMattersArticles/downloads/se0742.pdf on the CMS Web site. All other information remains the same.
Provider Types Affected
Ambulatory surgical centers (ASCs) submitting claims to Medicare carriers or fiscal intermediaries (Fish) for ASC services provided to Medicare beneficiaries.
Impact on Providers
This article is based on Change Request (CR) 5211, which updates the 2007 HCPCS codes and ASC payment rates, effective for services furnished on or after January 1, 2007.
Background
Section 5103 of the Deficit Reduction Act of 2005 (DRA) limits ASC payments to:
- The lesser of the Medicare Hospital Outpatient Prospective Payment System (OPPS) payment amount; or
- The ASC payment amount for services furnished on or after January 1, 2007.
Also, §1833(i)(1) of the Social Security Act requires that the list of payable ASC procedures be updated as least every two years.
CR5211, from which this article is taken, implements the required biennial ASC update, which includes changes made by the American Medical Association for the CY 2007 Common Procedural Terminology (CPT). These changes include replacing the ASC 2-digit payment group code designation next to the ASC-approved Healthcare Common Procedure Coding System (HCPCS) codes with a “yy” designation for these codes, which will be defined as “the procedure is approved to be performed in an ambulatory surgical center.”
CR5211 also revises the manner in which ASC payment groups are defined. The number of ASC payment groups that carriers and fiscal intermediaries (FI) currently use to identify ASC payment amounts for individual HCPCS codes is being expanded in order to accommodate the new payment amounts that will be assigned to certain ASC services in Calendar Year (CY) 2007 under the DRA requirement. The ASC payment groups will now be called ASC PRICER groups
The additional ASC PRICER groups reflect the DRA-driven payment amounts, which will be included in the ASC PRICER files that carriers, and certain FIs, use to process ASC facility claims. And lastly, CR5211 includes payment file retrieval instructions that your carriers and FIs will use to access the final payment files on, or after, the specified retrieval date provided in CMS’s notification. You should be aware that final ASC payment rates are established after publication of the OPPS final rule and the code change update will be published as part of the OPPS final rule in the Federal Register. This publication usually occurs in late October. Shortly after publication, you can reach this rule through a link at http://www.cms.hhs.gov/center/asc.asp on the CMS Web site.
Also note that your carriers and FIs will continue to use the wage index values contained in Transmittal 51, dated February 4, 2004, to calculate payment amounts for all type of service F Healthcare Common Procedural Coding System (HCPCS) codes until further notice. This transmittal is available at http://www.cms.hhs.gov/Transmittals/downloads/R51OTN.pdf on the CMS site.
Additional Information
For complete details, please see CR 5211, the official instruction issued to your carrier/intermediary regarding this change, located at http://www.cms.hhs.gov/Transmittals/downloads/R1134CP.pdf on the CMS Web site. The “2007 ASC Approved HCPCS Codes and Payment Rates” Changes are available at http://www.cms.hhs.gov/ASCPayment/01_Overview.asp on the CMS site.
If you have any questions, please contact your carrier at their toll-free number, which may be found at http://www.cms.hhs.gov/MLNProducts/downloads/CallCenterTollNumDirectory.zip on the CMS Web site.
Flu Shot Reminder
As a respected source of health care information, patients trust their doctors’ recommendations. If you have Medicare patients who haven’t yet received their flu shot, help protect them by recommending an annual influenza and a one time pneumococcal vaccination. Medicare provides coverage for flu and pneumococcal vaccines and their administration. – And don’t forget to immunize yourself and your staff. Protect yourself, your patients, and your family and friends. Get Your Flu Shot. Remember – Influenza vaccination is a covered Part B benefit. Note that influenza vaccine is NOT a Part D covered drug. For more information about Medicare’s coverage of adult immunizations and educational resources, go to CMS’s Web site:
http://www.cms.hhs.gov/MLNMattersArticles/downloads/SE0667.pdf.
Emergency -- Legislative Change Affecting the 2008 Medicare Physician Fee Schedule (MPFS), and Extension of the 2008 Participation Open Enrollment Period
News Flash – Test Your Medicare Claims Now! After you have submitted claims containing both National Provider Identifiers (NPIs) and legacy identifiers and those claims have been paid, Medicare urges you to send a small batch of claims now with only the NPI in the primary provider fields. If the results are positive, begin increasing the number of claims in the batch. (Reminder: For institutional claims, the primary provider fields are the Billing and Pay-to Provider fields. For professional claims, the primary provider fields are the Billing, Pay-to, and Rendering Provider fields. If the Pay-to Provider is the same as the Billing Provider, the Pay-to Provider does not need to be identified.)
Provider Types Affected
Physicians and other providers who bill Medicare contractors (fiscal intermediaries (FI), regional home health intermediaries (RHHI), carriers, and Medicare Administrative Contractors (A/B MAC)) for professional services paid under the MPFS.
What You Need to Know
CR5944, from which this article is taken, provides Medicare contractors with information about (and instructions for implementing) legislative changes to the 2008 MPFS, and about the extension of the Participation Open Enrollment period for 2008.
Effective for claims with dates of service January 1, 2008, through June 30, 2008, the update to the conversion factor will be 0.5%; and for claims with dates of service July 1, 2008 and after, will revert back to the previous payment methodology (the -10.1% update) that was outlined in the Final Rule, published in the Federal Register on November 27, 2007.
Additionally, the Centers for Medicare & Medicaid Services (CMS) has extended the 2008 Participation Open Enrollment period from December 31, 2007, to February 15, 2008 – therefore, it now runs from November 15, 2007, through February 15, 2008.
Background
The “Medicare, Medicaid, and SCHIP Extension Act of 2007” changes the rates of the 2008 Medicare Physician Fee Schedule (MPFS). CR5944 informs Medicare contractors of this legislative change to the 2008 MPFS; the release of the new MPFS files for them to load; the need to be ready to process beginning January 7, all claims with dates of service on or after January 1, 2008, which contain MPFS services; and the extension of the Participation Open Enrollment period for 2008.
MPFS Rate Change
Effective for claims with dates of service January 1, 2008, through June 30, 2008, the update to the conversion factor will be 0.5%.
It is important that you understand, however, that this new legislation only impacts the MPFS rates during the first half of 2008 (claims with dates of service January 1, 2008, through June 30, 2008). Claims with dates of service July 1, 2008, and after will revert back to the previous payment methodology (the -10.1% update) that was outlined in the Final Rule, published in the Federal Register on November 27, 2007.
Note: The legislation also extends the 1.0 floor on the work geographic practice cost index for six months, i.e., through June 30, 2008.
This MPFS rate change also impacts several other fee schedule rates which are MFPS-derived, including the anesthesia conversion factors, purchased diagnostic file, and ambulatory surgical center (ASC) facility rates; but does not impact services that are not paid under the MPFS (e.g., DME, clinical lab, etc.).
Physicians do not need to take any additional action in order for their claims to be paid at the new 0.5 percent rate. Medicare contractors are able to process claims for services paid under the Medicare Physician Fee Schedule that contain dates of service January 1 and after with the new 2008 rates. No adjustments should be necessary. Your Medicare contractors have been instructed to be ready to process all claims with 2008 dates of service with the new MPFS fees beginning January 7, 2008.
2008 Participation Open Enrollment Period Extension
Because this new legislation changes the 2008 MPFS rates, the CMS has extended the 2008 Participation Open Enrollment period from December 31, 2007, to February 15, 2008; – therefore, it now runs from November 15, 2007, through February 15, 2008.
The effective date for any Participation status change during the extension, however, remains January 1, 2008; and will be in force for the entire year. You should make your Participation decision for 2008 based on the two new fee rates (i.e., the 0.5% update that is effective January through June, and the -10.1% update that is effective July through December).
Note: CR5944 revises CR 5732 (Transmittal 1356 – Calendar Year (CY) 2008 Participation Enrollment and Medicare Participating Physicians and Suppliers Directory (MEDPARD) Procedures, dated October 19, 2007) to reflect the extension.
CR5944 also contains additional Medicare contractor instructions:
- Any contractor unable to meet the January 7, 2008, for processing claims date, can hold affected claims for up to 14 calendar days after receipt; but all held claims must be released for payment no later than January 15, 2008.
- Contractors will not automatically make adjustments for providers who change their Participation status after January 1, 2008, (you should begin billing claims according to the Participation decision that you have made). However, they will adjust claims based on Participation status changes that you bring to their attention.
- Your contractor will make the Participation Agreement available to you by placing it on their Web sites with Participation enrollment (and termination) instructions. They will mail (at no charge) hard copies of the new 2008 MPFS, on request, to any physicians/practitioners who do not have Internet access and are unable to view the new fees on the contractor Web site. They will, however, charge a reasonable fee for mailing a hard copy of the 2008 MPFS to providers that do have Internet access, but who want a hard copy for convenience. Further, they will handle physicians/practitioners’ requests for copies of the 2008 MPFS as customer services matters, and not as Freedom of Information Act (FOIA) requests; but will handle such requests from other members of the public as FOIA requests.
- Contractors will post the new fees on their Web sites as early as possible.
- Contractors will accept and process any Participation elections or withdrawals, made during the extended enrollment period that are received or post-marked on or before February 15, 2008.
Additional Information
You can find the official instruction, CR5944, issued to your carrier, FI, RHHI, or A/B MAC by visiting http://www.cms.hhs.gov/Transmittals/downloads/R312OTN.pdf on the CMS Web site.
If you have any questions, please contact your carrier, FI, RHHI, or A/B MAC at their toll-free number, which may be found at
http://www.cms.hhs.gov/MLNProducts/downloads/CallCenterTollNumDirectory.zip on the CMS Web site.
News Flash – It’s Not Too Late to Give and Get the Flu Shot! In the U.S., the peak of flu season typically occurs anywhere from late December through March; however, flu season can last as late as May. Each office visit presents an opportunity for you to talk with your patients about the importance of getting an annual flu shot and a one time pneumococcal vaccination. Protect yourself, your patients, and your family and friends by getting and giving the flu shot. Don’t Get the Flu. Don’t Give the Flu. Get Vaccinated! Remember – Influenza and pneumococcal vaccinations and their administration are covered Part B benefits. Note that influenza and pneumococcal vaccines are NOT Part D covered drugs. You and your staff can learn more about Medicare’s coverage of adult immunizations and related provider education resources, by reviewing Special Edition MLN Matters article SE0748 at
http://www.cms.hhs.gov/MLNMattersArticles/downloads/SE0748.pdf on the CMS Web site.
Additional Payable Healthcare Common Procedure Coding System (HCPCS) “C” Drug Codes in Ambulatory Surgical Centers (ASCs)
News Flash – The Ambulatory Surgical Center Fee Schedule Fact Sheet, which provides general information about the Ambulatory Surgical Center (ASC) Fee Schedule, ASC payments, and how ASC payment amounts are determined, is now available in downloadable format from the Centers for Medicare & Medicaid Services Medicare Learning Network at http://www.cms.hhs.gov/MLNProducts/downloads/AmbSurgCtrFeepymtfctsht508.pdf on the CMS Web site.
Provider Types Affected
Ambulatory Surgical Centers submitting claims to Medicare contractors (carriers and/or Part A/B Medicare Administrative Contractors (A/B MACs)) for services provided to Medicare beneficiaries.
Provider Action Needed
STOP – Impact to You
This article is based on Change Request (CR) 5885 which lists additional payable HCPCS “C” drug codes for Ambulatory Surgical Centers (ASCs).
CAUTION – What You Need to Know
CR 5885 instructs Medicare contractors to modify systems to accept four additional Healthcare Common Procedure Coding System (HCPCS) “C” codes (C9327, C9240, C9354, and C9355) and ensure that these HCPCS “C” codes are processed and paid using the same payment and claims processing policies issued by the Centers for Medicare & Medicaid Services (CMS) for the 2008 revision to the ASC payment system.
GO – What You Need to Do
See the Background and Additional Information Sections of this article for further details regarding these changes.
Background
A final list of Ambulatory Surgical Center (ASC) payable Healthcare Common Procedure Coding System (HCPCS) codes for January 1, 2008 was released in the recently issued ASC final rule (CMS-1392-FC) in the Federal Register (November 27, 2007).
However, there were four “C” codes recognized as payable in the ASC setting by the Centers for Medicare & Medicaid Services (CMS) that were approved too late in the process to be included in the Federal Register’s final rule issuance. In addition, these “C” codes were not annotated as ASC payable codes in the 2008 HCPCS file release.
CR 5885 instructs that the following HCPCS “C” codes will be included on the final version ASC DRUG file released by CMS, as discussed in CR 5831.
| HCPCS "C" Code | Descriptor | Effective Date |
| C9237 | Inj. Lanreotide acetate | January 1, 2008 |
| C9240 | Injection, ixabepilone | January 1, 2008 |
| C9354 | Vertias collagen matrix, cm2 | January 1, 2008 |
| C9355 | Neruomatriz nerve cuff, cm | January 1, 2008 |
CR 5885 also instructs Medicare contractors that when these HCPCS “C” codes are submitted by ASCs for payment, they will be processed and paid using the same payment and claims processing policies issued by CMS for the 2008 revision to the ASC payment system.
Medicare Contractors will make available to ASCs both:
- A list of all HCPCS that are payable in ASCs for 2008, including the additional HCPCS codes, and
- The wage adjusted payment rates of these HCPCS codes, for those ASCs in their jurisdiction.
Additional Information
The official instruction, CR 5885, issued to your Medicare carrier and A/B MAC regarding this change may be viewed at http://www.cms.hhs.gov/Transmittals/downloads/R1415CP.pdf on the CMS Web site.
If you have any questions, please contact your Medicare carrier or A/B MAC at their toll-free number, which may be found at
http://www.cms.hhs.gov/MLNProducts/downloads/CallCenterTollNumDirectory.zip on the CMS Web site.
News Flash – It’s Not Too Late to Get the Flu Shot. We are in the midst of flu season and a flu vaccine is still the best way to prevent infection and the complications associated with the flu. But re-vaccination is necessary each year because flu viruses change each year. Please encourage your Medicare patients who haven’t already done so to get their annual flu shot. And don’t forget to immunize yourself and your staff. Protect yourself, your patients, and your family and friends. Get Your Flu Shot – Not the Flu! Remember – Influenza vaccination is a covered Part B benefit. Note that influenza vaccine is NOT a Part D covered drug. Health care professionals and their staff can learn more about Medicare’s coverage of adult immunizations and related provider education resources, by reviewing Special Edition MLN Matters article SE0748 at
http://www.cms.hhs.gov/MLNMattersArticles/downloads/SE0748.pdf on the CMS Web site.
Ambulance Providers
A recent review of ambulance transport claims has demonstrated a significant concern regarding billing for emergency transport to destination of home, skilled nursing facilities and other sites to which it is not normally reasonable to run emergency traffic.
Please inform your billing staff that HCPCS Codes A0427 and A0429 should not be billed with destination modifiers (second letter) –D, -E, -J, -N, -R. No medical necessity exists for an emergency transfer of a patient to one of these destinations. Similarly the emergency transfers using destinations –P and –X should be rare and should be clearly justified in the run ticket documentation. An example of this is a rural county with no hospital, an unstable, critically ill or injured patient where the unit stops at a physician’s office for physician assistance in stabilizing the patient prior to proceeding on to the hospital emergency department.
Ambulatory Surgical Center (ASC) Claims Processing Manual Clarification
Note: This article was revised on January 24, 2008, to add a reference to SE0742. SE0742 announced that CMS was implementing significant revisions to the payment system for ASC services beginning with services rendered on or after January 1, 2008. SE0742 may be found at http://www.cms.hhs.gov/MLNMattersArticles/downloads/se0742.pdf on the CMS Web site. All other information remains the same.
Do you have your NPI? National Provider Identifiers (NPIs) will be required on claims sent on or after May 23, 2007. Every health care provider needs to get an NPI. Learn more about the NPI and how to apply for an NPI by visiting http://www.cms.hhs.gov/NationalProvIdentStand/ on the CMS Web site.
Provider Types Affected
Providers and suppliers of ambulatory surgical center (ASC) services
Provider Action Needed
This article is for informational purposes. CR5026 revises the Medicare Claims Processing Manual, Chapter 14 (Ambulatory Surgical Centers), Sections 10.3 (Services Furnished in ASCs Which Are Not ASC Facility Services) and 10.4 (Coverage of Services in ASCs Which Are Not ASC Facility Services) to clarify policy regarding the provision, coverage, and payment of services furnished in an ASC.
Background
Medicare conventionally reimburses ASCs in the form of a single payment that includes all “facility services” that the ASC furnishes in connection with a covered procedure. However, an ASC (perhaps as part of a medical complex that may include other entities, such as an independent laboratory, supplier of durable medical equipment, or a physician’s office) may also furnish a number of covered items and services that are not considered facility services.
Be aware that such entities, which are separate from the ASC, are covered separately under Part B. Further, in general, the items or services that these entities provide are not considered ASC services, and are therefore not included in the ASC payment, but are rather covered and paid for under the applicable Part B provisions.
Examples of such services include:
- Physicians’ services;
- Durable medical equipment (DME);
- Implantable DME;
- Prosthetic devices;
- Ambulance services;
- Leg, arm, back and neck braces;
- Artificial legs, arms and eyes; and
- Services of an independent laboratory.
More details about each of these services are shown in Table 1, below.
Table 1 - Examples of Services Not Included in the ASC Facility Rate
| Items or Services | Who Receives Payment | Submit Bills To |
Physicians’ services - Anesthesiologists administering or supervising the administration of anesthesia to ASC patients and the patients’ recovery from the anesthesia; - Routine pre- or post- operative services, such as office visits, consultations, diagnostic tests, suture removal, dressing changes, and other services which are usually included in the physician fee for a given surgical procedure. |
Physician | Carrier |
| Non-implantable durable medical equipment (DME) to ASC patients for in-home use ASCs who sell, lease, or rent items of DME to patients, are treated as DME suppliers. All of the ordinary DME-applicable rules and conditions apply to the ASC, including obtaining a supplier number and billing the DMERC as required. |
Supplier |
DMERC |
| Implantable DME and accessories | ASC | Carrier |
Items or Services Who Receives Submit Bills Payment To
| Items or Services | Who Receives Payment | Submit Bills To |
ASCs who furnish implantable DME items to patients,bil the local acarrier for the surgical procedure and the implantable device. |
||
| Non-implantable prosthetic devices ASCs who furnish non-implantable prosthetic devices to patients are treated as suppliers, and all the ordinary DME-applicable rules and conditions apply to the ASC, including obtaining a supplier number and billing the DMERC as required. |
Suppier |
DMERC |
| Implantable prosthetic devices except intraocular lenses (IOLs and NTIOLs [new technology intraocular lenses]), and accessories ASCs may bill and receive separate payment for prosthetic devices (other than intraocular lenses [IOLs]) that are implanted, inserted, or otherwise applied by surgical procedures on the ASC list of approved procedures. The ASC bills the local Carrier and receives payment according to the DMEPOS fee schedule. An intraocular lens (IOL) inserted during or subsequent to cataract surgery in an ASC is included in the facility payment rate. ASCs may receive additional payment for approved NTIOLs that are furnished in an ASC during or subsequent to certain cataract procedures. |
ASC | Carrier |
Ambulance services |
Certified ambulance supplier | Carrier |
| Leg, Arm, back and neck braces These items of equipment are not included in the ASC Facility payment amount, but are covered under Part B. ASCs who furnish these items to pateints are treated as suppliers, and all the rules and conditions ordinarily a supplier number and billing the DMERC as required. |
Supplier | DMERC |
| Artifical legs, arms, and eyes These items of equipment are not included in the ASC facillity payment rate, but are covered under part B. ASCs who furnish these items to patients are treated as suppliers, and all the rules and conditions ordinarily applicable to suppliers apply to the ASC, including obtaining as supplier number and billing the DMERC as required. |
Supplier | DMERC |
| Services furnished by an independent laboratory Only very limited numbers and types of diagnostic tests are considered ASC facility services and these are included in the ASC facility payment rate. Since coverage of diagnostic lab tests in facilities other than physicians’ offices, rural health clinics or hospitals is limited to facilities that meet the statutory definition of an independent laboratory, in most cases diagnostic tests performed directly by an ASC are not considered ASC facility services (in fact are usually not covered under Medicare). ASC laboratories must be CLIA Certified and will need to enroll with the carrier as a laboratory. Otherwise, the ASC makes arrangement with a covered laboratory or laboratories for laboratory services. If the ASC has a certified independent laboratory, the laboratory itself bills the carrier. |
Certified lab. ASCs can receive lab certification and a CLIA number | Carrier |
Procedures NOT On the ASC list |
Physician | Carrier |
Additional Information
You can find more information about services not included in the ASC facility rate (and the coverage of such services) by reviewing CR5026, which is available at http://www.cms.hhs.gov/Transmittals/downloads/R975CP.pdf on the CMS Web site.
The revised Medicare Claims Processing Manual, Chapter 14 (Ambulatory Surgical Centers), Sections 10.3 (Services Furnished in ASCs Which Are Not ASC Facility Services) and 10.4 (Coverage of Services in ASCs Which Are Not ASC Facility Services) are attached to CR5026.
If you have any questions, please contact your carrier at their toll-free number, which may be found at http://www.cms.hhs.gov/MLNProducts/downloads/CallCenterTollNumDirectory.zipon the CMS Web site.
Change in the Amount in Controversy Requirement for Administrative Law Judge Hearings and Federal District Court Appeals
News Flash – Test Your Medicare Claims Now! After you have submitted claims containing both National Provider Identifiers (NPIs) and legacy identifiers and those claims have been paid, Medicare urges you to send a small batch of claims now with only the NPI in the primary provider fields. If the results are positive, begin increasing the number of claims in the batch. (Reminder: For institutional claims, the primary provider fields are the Billing and Pay-to Provider fields. For professional claims, the primary provider fields are the Billing, Pay-to, and Rendering Provider fields. If the Pay-to Provider is the same as the Billing Provider, the Pay-to Provider does not need to be identified.)
Provider Types Affected
Physicians, providers, and suppliers submitting claims to Medicare contractors (carriers, DME Medicare Administrative Contractors (DME MACs), Fiscal Intermediaries (FIs), Part A/B Medicare Administrative Contractors (A/B MACs), and/or Regional Home Health Intermediaries (RHHIs)) for services provided to Medicare beneficiaries
Impact on Providers
This article is based on Change Request (CR) 5897 which notifies Medicare contractors of an increase in the Amount in Controversy (AIC) required to sustain Administrative Law Judge (ALJ) and Federal District Court appeal rights beginning January 1, 2008. The amount remaining in controversy requirement for ALJ hearing requests made before January 1, 2008, is $110. The amount remaining in controversy requirement for requests made on or after January 1, 2008, is $120. For Federal District Court review, the amount remaining in controversy goes from $1,130 for requests prior to January 1, 2008, to $1,180 for requests on or after that date.
Background
The Medicare claims appeal process was amended by the Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000 (BIPA). In addition, the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 provides for annual reevaluation (beginning in 2005) of the dollar amount in controversy required for an Administrative Lay Judge (ALJ) hearing and Federal District Court review.
Change Request (CR) 5897 revises the Medicare Claims Processing Manual (Publication 100-4, Chapter 29, Section 330.1 and Section 345.1) to update the Amount In Controversy (AIC) required for an ALJ hearing or Federal District Court review. As of January 1, 2008, the amount remaining in controversy must be at least $120 for an ALJ hearing or at least $1,180 for a Federal District Court review requested on or after January 1, 2008.
Additional Information
The official instruction, CR5897, issued to your carrier, FI, RHHI, A/B MAC, and DME MAC regarding this change may be viewed at http://www.cms.hhs.gov/Transmittals/downloads/R1437CP.pdf on the Centers for Medicare & Medicaid Services (CMS) Web site.
If you have any questions, please contact your carrier, FI, RHHI, A/B MAC, DMERC, or DME MAC at their toll-free number, which may be found at http://www.cms.hhs.gov/MLNProducts/downloads/CallCenterTollNumDirectory.zip on the CMS Web site.
News Flash – It’s Not Too Late to Give and Get the Flu Shot! In the U.S., the peak of flu season typically occurs anywhere from late December through March; however, flu season can last as late as May. Each office visit presents an opportunity for you to talk with your patients about the importance of getting an annual flu shot and a one time pneumococcal vaccination. Protect yourself, your patients, and your family and friends by getting and giving the flu shot. Don’t Get the Flu. Don’t Give the Flu. Get Vaccinated! Remember – Influenza and pneumococcal vaccinations and their administration are covered Part B benefits. Note that influenza and pneumococcal vaccines are NOT Part D covered drugs. You and your staff can learn more about Medicare’s coverage of adult immunizations and related provider education resources, by reviewing Special Edition MLN Matters article SE0748 at http://www.cms.hhs.gov/MLNMattersArticles/downloads/SE0748.pdf on the CMS Web site.
Clarification of Bone Mass Measurement (BMM) Billing Requirements Issued in CR 5521
News Flash – Medicare Remit Easy Print (MREP) software allows professional providers and suppliers to view and print the Health Insurance Portability and Accountability Act (HIPAA) compliant 835. This software, which is available for free can be used to access and print RA information, including special reports, from the HIPAA 835. Please go to your Carrier or DME MAC’s Web site to download the MREP software. To find your carrier or DME MAC’s web address, see http://www.cms.hhs.gov/MLNProducts/downloads/CallCenterTollNumDirectory.zip on the CMS Web site.
Provider Types Affected
Physicians, providers, and suppliers submitting claims to Medicare contractors (carriers, Fiscal Intermediaries (FIs), and/or Part A/B Medicare Administrative Contractors (A/B MACs)) for BMM services provided to Medicare beneficiaries.
Provider Action Needed
This article is based on Change Request (CR) 5847 which clarifies the claims processing instructions contained in CR 5521. Only those business requirements changing from CR 5521 are listed in CR 5847, and the BMM benefit policy is not changing. The basic clarification is that Medicare allows codes other than CPT code 77080 (i.e., 76977, 77078, 77079, 77081, 77083, and G0130) to be paid even though claims for such services report both a screening diagnosis code and an osteoporosis code.
Background
The Social Security Act (Sections 1861(s)(15) and (rr)(1)) (as added by the Balanced Budget Act of 1997 (BBA; §4106)) standardize Medicare coverage of medically necessary BMMs by providing for uniform coverage under Medicare Part B. Effective for dates of service on and after January 1, 2007, the Calendar Year (CY) 2007 Physician Fee Schedule (PFS) final rule expanded the number of beneficiaries qualifying for BMM by reducing the dosage requirement for glucocorticoid (steroid) therapy from 7.5 mg of prednisone per day to 5.0 mg. It also changed the definition of BMM by removing coverage for a single-photon absorptiometry as it is not considered reasonable and necessary under the Social Security Act (Section 1862 (a)(1)(A)) . Finally, it required in the case of monitoring and confirmatory baseline BMMs, that they be performed with a dual-energy x-ray absorptiometry (axial) test.
The Centers for Medicare & Medicaid Services (CMS) issued change request (CR) 5521 (Transmittal 70; May 11, 2007) to provide benefit policy and claims processing instructions for BMM tests. CMS has learned that the updated policy described in CR 5521 is not being implemented uniformly and some covered services are being denied in error.
You can review the MLN Matters article related to CR 5521 at http://www.cms.hhs.gov/MLNMattersArticles/downloads/mm5521.pdf on the CMS Web site. CR 5847 clarifies the claims processing instructions contained in CR 5521 and lists only those business requirements changing from CR 5521. The key clarifications are as follows, effective for dates of services on and after January 1, 2007, the following apply to BMM:
- Certain BMM tests are covered when used to screen patients for osteoporosis subject to the frequency standards described in section 80.5.5 of the Medicare Benefit Policy Manual, which may be found at http://www.cms.hhs.gov/Manuals/IOM/list.asp on the CMS Web site.
- Medicare Contractors will pay claims for screening tests when coded as follows:
- Contains Current Procedural Terminology (CPT) procedure code 77078, 77079, 77080, 77081, 77083, 76977 or G0130, and
- Contains a valid ICD-9-CM diagnosis code indicating the reason for the test is postmenopausal female, vertebral fracture, hyperparathyroidism, or steroid therapy. Contractors are to maintain local lists of valid codes for the benefit’s screening categories.
- Contractors will deny claims for screening tests when coded as follows:
- Contains CPT procedure code 77078, 77079, 77081, 77083, 76977 or G0130, but
- Does not contain a valid ICD-9-CM diagnosis code indicating the reason for the test is postmenopausal female, vertebral fracture, hyperparathyroidism, or steroid therapy.
- Dual-energy x-ray absorptiometry (axial) tests are covered when used to monitor FDA-approved osteoporosis drug therapy subject to the 2-year frequency standards described in section 80.5.5 of the Medicare Benefit Policy Manual.
- Contractors will pay claims for monitoring tests when coded as follows:
- Contains CPT procedure code 77080, and
- Contains 733.00, 733.01, 733.02, 733.03, 733.09, 733.90, or 255.0 as the ICD-9-CM diagnosis code.
- Contractors will deny claims for monitoring tests when coded as follows:
- Contains CPT procedure code 77078, 77079, 77081, 77083, 76977 or G0130, and
- Contains 733.00, 733.01, 733.02, 733.03, 733.09, 733.90, or 255.0 as the ICD-9-CM diagnosis code, but does not contain a valid ICD-9-CM diagnosis code from the local lists of valid ICD-9-CM diagnosis codes maintained by the Medicare contractor for the benefit’s screening categories indicating the reason for the test is postmenopausal female, vertebral fracture, hyperparathyroidism, or steroid therapy.
- Single photon absorptiometry tests are not covered. Contractors will deny CPT procedure code 78350.
Note: As mentioned, these are clarifications and the BMM benefit policy is not changing. Also, note that while Medicare contractors will not search their files to reprocess claims already processed, they will adjust claims that you bring to their attention.
Additional Information
The official instruction, CR5847, issued to your Medicare carrier, FI, and A/B MAC regarding this change may be viewed at http://www.cms.hhs.gov/Transmittals/downloads/R1416CP.pdf on the CMS Web site.
If you have any questions, please contact your Medicare carrier, FI, or A/B MAC at their toll-free number, which may be found at http://www.cms.hhs.gov/MLNProducts/downloads/CallCenterTollNumDirectory.zip on the CMS Web site.
News Flash – It’s Not Too Late to Get the Flu Shot. We are in the midst of flu season and a flu vaccine is still the best way to prevent infection and the complications associated with the flu. But re-vaccination is necessary each year because flu viruses change each year. Please encourage your Medicare patients who haven’t already done so to get their annual flu shot. And don’t forget to immunize yourself and your staff. Protect yourself, your patients, and your family and friends. Get Your Flu Shot – Not the Flu! Remember – Influenza vaccination is a covered Part B benefit. Note that influenza vaccine is NOT a Part D covered drug. Health care professionals and their staff can learn more about Medicare’s coverage of adult immunizations and related provider education resources, by reviewing Special Edition MLN Matters article SE0748 at http://www.cms.hhs.gov/MLNMattersArticles/downloads/SE0748.pdf on the CMS Web site.
Clarification Regarding the Coordination of Benefits Agreement (COBA) Medigap Claim-based Crossover Process
News Flash – The Hospice Payment System Fact Sheet, which offers providers information about the Medicare hospice benefit, is now available from the Centers for Medicare & Medicaid Services Medicare Learning Network in downloadable format at
http://www.cms.hhs.gov/MLNProducts/downloads/hospice_pay_sys_fs.pdf on the CMS Web site
Note: This article was revised on January 30, 2008, to show the correct implementation date (see above), which is February 1, 2008. All other information remains the same.
Provider Types Affected
Physicians, providers, and suppliers submitting claims to Medicare contractors (carriers, Durable Medical Equipment Medicare Administrative Contractors (DME MACs), and/or Part A/B Medicare Administrative Contractors (A/B MACs)) for Medicare Part B services provided to Medicare beneficiaries.
Provider Action Needed
STOP – Impact to You
This article is based on Change Request (CR) 5837 which clarifies instructions regarding the Coordination of Benefits Agreement (COBA) Medigap claim-based crossover process.
CAUTION – What You Need to Know
CR 5837 provides formal confirmation of recent Centers for Medicare & Medicaid Services (CMS) decision to not require Medicare Part B contractors (including Durable Medical Equipment Medicare Administrative Contractors (DME MACs) to update their internal insurer tables or files with each Medigap insurer’s newly assigned Coordination of Benefits Agreement (COBA) Medigap claim-based ID, as was previously prescribed in CR 5662. In addition, CR 5837 conveys clarifying provider billing requirements in relation to Medigap claim-based crossovers.
GO – What You Need to Do
See the Background and Additional Information Sections of this article for further details regarding
these changes.
Background
Effective October 1, 2007, the CMS transferred responsibility for the mandatory Medigap crossover process (also known as the “Medicare claim-based crossover process”) to its Coordination of Benefits Contractor. With this change, Part B contractors, including A/B MACs and DME MACs:
- No longer maintain crossover relationships with Medigap insurers, and
- No longer bill such entities for crossover claims effective with the last claims file that they transmit to these entities no later than October 31, 2007.
In a directive issued on September 18, 2007, CMS communicated to Medicare Part B contractors (carriers, DME MACs, and A/B MACs) its decision that they are not required to update their internal insurer files or tables with the Coordination of Benefits Contractor (COBC)-assigned COBA Medigap claim-based identifiers (IDs). This is because, as discussed in Change Request (CR) 5601, the contractors’ front-end system now simply verifies that a Medigap claim-based crossover identifier on an incoming claim is syntactically correct (5 digits, beginning with a “5”). CMS’ Common Working File (CWF) system is now tasked with validation of the actual ID submitted on incoming claims.
The September 18, 2007, directive represented a departure from previous guidance communicated in CR5662 (see MLN Matters article, MM5662, at
http://www.cms.hhs.gov/MLNMattersArticles/downloads/MM5662.pdf on the CMS Web site), in which CMS provided for transitional updating of the contractors’ internal insurer files/tables prior to October 1, 2007, once the COBC had:
- Assigned COBA Medigap claim-based IDs to the various Medigap insurers, and
- Deemed Medigap insurers “production-ready.”
- CMS also required Medicare contractors to post language on their provider Web sites stipulating that:
- Providers are not to begin including the new COBA Medigap claim-based IDs on incoming Part B claims or claims for durable medical equipment, prosthetics, orthotics, and medical supplies (DMEPOS) before October 1, 2007.
CR 5837 instructs Part B contractors (including A/B MACs and DME MACs) that they are not required to update their internal insurer files/tables following a Medigap insurer’s readiness to move into production with the COBC. This requirement formerly applied to situations where CMS expected that contractors update their internal insurer files/tables prior to October 1, 2007, in accordance with CR 5662 (Transmittal 283). These Part B contractors may retain their older Other Carrier Name and Address (OCNA) or N-key identifiers within their internal insurer files/tables for purposes of avoiding system issues or for the printing of post-hoc beneficiary-requested Medicare Summary Notices (MSNs). However, in accordance with CR 5601, at http://www.cms.hhs.gov/transmittals/downloads/R1242CP.pdf on the CMS Web site, contractors will have disabled the logic that they formerly used to tag claims for crossover to Medigap insurers effective prior to claims they received for processing on October 1, 2007.
Effective with CR 5837, all Part B contractors (including A/B MACs and DME MACs) will discontinue publication of their routine Medigap newsletters. These contractors may, however, at their discretion, publish one last edition of this newsletter if desired to include the provider education language that follows:
In accordance with the language modification to MSN message 35.3
—“A copy of this notice will not be forwarded to your Medigap insurer because the information submitted on the claim was incomplete or invalid. Please submit a copy of this notice to your Medigap insurer.”—which contractors made as part of Transmittal 1242, CR 5601, all Part B contractors, including A/B MACs, and DME MACs shall make available a Spanish translation of the modified MSN message, which shall read as follows: “No se enviará copia de esta notificación a su asegurador de Medigap debido a que la información estaba incompleta o era inválida. Favor de someter una copia de esta notificación a su asegurador Medigap.”
All Part B contractors (including A/B MACs, and DME MACs) are to inform their associated billing providers that are exempted from billing their claims electronically under the Administrative Simplification Compliance Act (ASCA) that they should only be entering the newly assigned 5-byte COBA Medigap claim-based ID (range 55000 to 59999) with item 9-D of the CMS-1500 claim form for purposes of triggering a crossing over of the claim to a Medigap insurer.
All Part B contractors (including A/B MACs, and DME MACs) are also to provide a link on their provider Web sites (preferably under “Hot Topics”) to the recently published special edition MLN article (SE0743 at
http://www.cms.hhs.gov/MLNMattersArticles/downloads/SE0743.pdf on the CMS Web site) that clarifies for providers the differences between:
- Medigap crossover that is accomplished via the automatic, eligibility file-based crossover process, and
- The Medigap claim-based crossover process, which is triggered by information that they include on incoming claim.
Providers should note that the listing at http://www.cms.hhs.gov/COBAgreement/Downloads/Medigap%20Claim-based%20COBA%20IDs%20for%20Billing%20Purpose.pdf on the CMS COB Web site is:
- Complete and up-to-date, and
- The only source for the identifiers to be included on incoming claims for purposes of triggering crossovers to those Medigap insurers that do not participate fully in the automatic crossover process.
Additional Information
The official instruction, CR 5837, was issued in two transmittals issued to your Medicare carrier, DME MAC, or A/B MAC. Those transmittals may be viewed at http://www.cms.hhs.gov/Transmittals/downloads/R1420CP.pdf and http://www.cms.hhs.gov/Transmittals/downloads/R135FM.pdf on the CMS Web site. These transmittals make revisions to the Medicare Claims Processing and Medicare Financial Management Manuals, respectively
If you have any questions, please contact your Medicare carrier, DME MAC, or A/B MAC at their toll-free number, which may be found at
http://www.cms.hhs.gov/MLNProducts/downloads/CallCenterTollNumDirectory.zip on the CMS Web site.
News Flash – It’s Not Too Late to Get the Flu Shot. We are in the midst of flu season and a flu vaccine is still the best way to prevent infection and the complications associated with the flu. But re-vaccination is necessary each year because flu viruses change each year. Please encourage your Medicare patients who haven’t already done so to get their annual flu shot. – And don’t forget to immunize yourself and your staff. Protect yourself, your patients, and your family and friends. Get Your Flu Shot – Not the Flu! Remember - Influenza vaccination is a covered Part B benefit. Note that influenza vaccine is NOT a Part D covered drug. Health care professionals and their staff can learn more about Medicare’s coverage of adult immunizations and related provider education resources, by reviewing Special Edition MLN Matters article SE0748 at http://www.cms.hhs.gov/MLNMattersArticles/downloads/SE0748.pdf on the CMS Web site.
Clarification to CR 5744 - Payment Allowance Update for the Influenza Virus Vaccine CPT 90660 and further instruction regarding the Pneumococcal Vaccine Current Procedural Terminology (CPT) 90669
Note: This article was revised on March 7, 2008, to delete a reference to “institutional providers” in the first bullet point on page two regarding the use of HCPCS code G0009. The sentence referencing that code has been changed to begin with “providers” rather than “institutional providers.” All other information remains the same.
News Flash – Test Your Medicare Claims Now! After you have submitted claims containing both National Provider Identifiers (NPIs) and legacy identifiers and those claims have been paid, Medicare urges you to send a small batch of claims now with only the NPI in the primary provider fields. If the results are positive, begin increasing the number of claims in the batch. (Reminder: For institutional claims, the primary provider fields are the Billing and Pay-to Provider fields. For professional claims, the primary provider fields are the Billing, Pay-to, and Rendering Provider fields. If the Pay-to Provider is the same as the Billing Provider, the Pay-to Provider does not need to be identified.)
Provider Types Affected
Physicians, hospitals, and other providers who bill Medicare contractors (fiscal intermediaries (FI), carriers, or A/B MACs) for providing influenza and pneumococcal vaccines to Medicare beneficiaries.
What You Need to Know
CR 5910, from which this article is taken, clarifies CR 5744 (Payment Allowances for the Influenza Virus Vaccine and the Pneumococcal Vaccine When Payment is Based on 95 Percent of the Average Wholesale Price (AWP)), released October 26, 2007. It provides Medicare contractors additional instructions regarding the pediatric pneumococcal vaccine CPT code 90669, and the updated payment allowance for the nasal influenza virus vaccine CPT code 90660.
The Medicare Part B payment allowance for CPT 90660 is $22.031, effective September 19, 2007. Make sure that your billing staffs are aware of these CPT code updates.
Background
Change Request 5744 (Payment Allowances for the Influenza Virus Vaccine and the Pneumococcal Vaccine When Payment is Based on 95 Percent of the Average Wholesale Price (AWP)), released October 26, 2007; provided the payment allowances for Pneumococcal Vaccine Current Procedural Terminology (CPT) codes 90732 and 90669, and Influenza Virus Vaccines CPT codes 90655, 90656, 90657, 90658, and 90660).
CR 5910, from which this article is taken, augments CR 5744 by providing additional instructions regarding pediatric pneumococcal vaccine CPT code 90669, and the updated payment allowance for the nasal influenza virus vaccine CPT code 90660. These changes are:
- CPT Code 90669 – Effective January 1, 2008, FIs, carriers, and A/B MACs will accept claims containing 90669 for pneumococcal vaccine. In order to facilitate appropriate payment for CPT code 90669 (Pneumococcal conjugate vaccine, polyvalent, for children under 5 years, for intramuscular use), carriers and A/B MACs will use a payment indicator of “1” and the deductible indicator of “1.” Providers should bill HCPCS code G0009 when billing for services on or after January 1, 2008, for the administration of CPT code 90669.
- CPT Code 90660 - On September 19, 2007, the Food and Drug Administration (FDA) approved FluMist for the 2007-2008 influenza season. Thus, your FI, carrier, or A/B MAC may cover CPT 90660 (FluMist, a nasal influenza vaccine) if it determines that its use is medically reasonable and necessary for the beneficiary. The Medicare Part B payment allowance for CPT 90660 is $22.031, effective September 19, 2007, except where the vaccine is furnished in the hospital outpatient department. This supersedes the allowance figure provided in CR 5744.
Note: All other instructions in CR 5744 remain in effect.
Please note that, except when the vaccine is furnished in the hospital outpatient department, the Medicare Part B payment allowance limits for influenza and pneumococcal vaccines are 95% of the average wholesale price (AWP), as reflected in the published compendia payment for the vaccine is based on reasonable cost. Also note that annual Part B deductible and coinsurance amounts do not apply; and that all physicians, non-physician practitioners, and suppliers who administer the influenza virus and pneumococcal vaccinations must take assignment on the claim for the vaccine.
Finally, your Medicare contractor will not search their files to either retract payment for claims already paid or to retroactively pay claims, but will adjust claims that you bring to their attention.
Additional Information
You can find more information about the additional information regarding CPT codes 90669 and 90660 by going to CR 5910, located at http://www.cms.hhs.gov/Transmittals/downloads/R1461CP.pdf on the CMS Web site. You might also want to review the MLN Matters article related to CR 5744. You can find that article at http://www.cms.hhs.gov/MLNMattersArticles/downloads/MM5744.pdf on the CMS Web site.
If you have any questions, please contact your FI, carrier, or A/B MAC at their toll-free number, which may be found at http://www.cms.hhs.gov/MLNProducts/downloads/CallCenterTollNumDirectory.zip on the CMS Web site.
News Flash – It’s Not Too Late to Give and Get the Flu Shot! In the U.S., the peak of flu season typically occurs anywhere from late December through March; however, flu season can last as late as May. Each office visit presents an opportunity for you to talk with your patients about the importance of getting an annual flu shot and a one time pneumococcal vaccination. Protect yourself, your patients, and your family and friends by getting and giving the flu shot. Don’t Get the Flu. Don’t Give the Flu. Get Vaccinated! Remember – Influenza and pneumococcal vaccinations and their administration are covered Part B benefits. Note that influenza and pneumococcal vaccines are NOT Part D covered drugs. You and your staff can learn more about Medicare’s coverage of adult immunizations and related provider education resources, by reviewing Special Edition MLN Matters article SE0748 at http://www.cms.hhs.gov/MLNMattersArticles/downloads/SE0748.pdf on the CMS Web site.
Clinical Lab: New Automated Test for the Automated Multi-channel Chemistry Code (AMCC) Panel Payment Algorithm
News Flash – Test Your Medicare Claims Now! After you have submitted claims containing both National Provider Identifiers (NPIs) and legacy identifiers and those claims have been paid, Medicare urges you to send a small batch of claims now with only the NPI in the primary provider fields. If the results are positive, begin increasing the number of claims in the batch. (Reminder: For institutional claims, the primary provider fields are the Billing and Pay-to Provider fields. For professional claims, the primary provider fields are the Billing, Pay-to, and Rendering Provider fields. If the Pay-to Provider is the same as the Billing Provider, the Pay-to Provider does not need to be identified.)
Provider Types Affected
All physicians and providers, who submit claims for the AMCC to Medicare contractors (carriers, Medicare Administrative Contractors (A/B MACs), and Fiscal Intermediaries (FIs)) for services provided to Medicare beneficiaries.
Provider Action Needed
STOP – Impact to You
The Centers for Medicare & Medicaid Services (CMS) issued Change Request (CR) 5874 to alert providers that existing current procedural terminology (CPT) code 82330, Calcium; ionized is being paid as in individual test and was not included in the AMCC Panel Payment Algorithm. That changes effective July 1, 2008.
CAUTION – What You Need to Know
Effective July 1, 2008, CPT 82330 will become an automated chemistry test within the AMCC Panel Payment Algorithm for payment purposes.
GO – What You Need to Do
Make certain your office staffs are aware of this change.
Background
Effective January 1, 2008, the CPT Editorial Panel created a new code 80047 Basic metabolic panel (Calcium, ionized) which is an automated multi-channel chemistry (AMCC) code and is currently included in the automated multi-channel chemistry code (AMCC) Panel Payment Algorithm. The new code 80047 is comprised of eight component test codes (see table below). Also, new code 80047 is not a replacement for code 80048 Basic metabolic panel. Both codes 80048 and 80047 are included in the 2008 clinical laboratory fee schedule.
Key Points
- In order to determine payment for the new code 80047 using the AMCC Panel Payment Algorithm, existing code 82330, Calcium; ionized, will be added as an AMCC panel code.
- Payment code ATP23 has also been included in the clinical laboratory fee schedule data file to correspond to the AMCC panel code addition.
- The CPT code 80047 Basic metabolic panel (Calcium, ionized) is comprised of:
- Calcium; ionized (82330);
- Carbon dioxide (82374);
- Chloride (82435);
- Creatinine (82565);
- Glucose (82947);
- Potassium (84132);
- Sodium (84295); and
- Urea Nitrogen (BUN) (84520)
For ESRD dialysis patients, CPT code 82330 Calcium; ionized will be included in the calculation for the 50/50 rule (Pub 100-04, Chapter 16, Section 40.6). When CPT code 82330 is billed as a substitute for CPT code 82310, Calcium; total, it should be billed with modifier CD or CE. When CPT code 82330 is billed in addition to CPT 82310, it should be billed with CF modifier.
Note that, in accordance with the Medicare Claims Processing Manual, section 40.6.1, the new panel code 80047 cannot be billed for services ordered through an ESRD facility. All tests billed for services ordered through an ESRD facility must be billed individually, not in an organ disease panel. The Medicare Claims Processing Manual is available at http://www.cms.hhs.gov/Manuals/IOM/list.asp on the CMS Web site.
Additional Information
To see the official instruction (CR5874) issued to your Medicare Carrier, FI, or A/B MAC, refer to http://www.cms.hhs.gov/Transmittals/downloads/R83BP.pdf on the CMS Web site.
If you have questions, please contact your Medicare
Carrier, FI, or A/B MAC at their toll-free number
which may be found at http://www.cms.hhs.gov/MLNProducts/downloads/CallCenterTollNumDirectory.zip on the CMS Web site.
News Flash – It’s Not Too Late to Give and Get the Flu Shot! In the U.S., the peak of flu season typically occurs anywhere from late December through March; however, flu season can last as late as May. Each office visit presents an opportunity for you to talk with your patients about the importance of getting an annual flu shot and a one time pneumococcal vaccination. Protect yourself, your patients, and your family and friends by getting and giving the flu shot. Don’t Get the Flu. Don’t Give the Flu. Get Vaccinated! Remember – Influenza and pneumococcal vaccinations and their administration are covered Part B benefits. Note that influenza and pneumococcal vaccines are NOT Part D covered drugs. You and your staff can learn more about Medicare’s coverage of adult immunizations and related provider education resources, by reviewing Special Edition MLN Matters article SE0748 at
http://www.cms.hhs.gov/MLNMattersArticles/downloads/SE0748.pdf on the CMS Web site.
Attention Part B Medicare Providers: Modifier Finder Tool Now Available on the CIGNA Government Services Web site!
Are you a Part B Medicare provider who routinely uses modifiers in billing your claims to Medicare? If so, CIGNA Government Services has a new online tool just for you!
The Modifier Finder tool has been designed to aid Medicare providers in using modifiers correctly. You may search this database by modifier or keyword. All records matching your search criteria will be returned for your review. Or, if you wish, you may also view the entire listing of modifiers, their definitions, and additional billing information by clicking on the “Show all Modifiers” option.
The new Modifier Finder Tool is available at the following link to the CIGNA Government Services Web site: http://www.cignagovernmentservices.com/medicare_dynamic/modifiers/search.asp.
Emergency Update to the 2008 Medicare Physician Fee Schedule Database (MPFSDB)
News Flash – An additional election period for the Competitive Acquisition Program (CAP) for Medicare Part B drugs will start on January 15 and run through February 15, 2008, to give physicians a chance to take advantage of new changes to the program that began on January 1, 2008. The CAP is a voluntary program that provides an alternative to ASP for physicians to obtain certain Part B drugs. More information about the CAP is available at http://www.cms.hhs.gov/CompetitiveAcquisforBios/01_overview.asp on the CMS Web site.
Provider Types Affected
Physicians, other practitioners, providers, and suppliers submitting claims to Medicare contractors (carriers, Fiscal Intermediaries (FIs), and/or Part A/B Medicare Administrative Contractors (A/B MACs)) for services provided to Medicare beneficiaries and paid under the MPFSDB.
Provider Action Needed
The article is based on Change Request (CR) 5902 which amends payment files that were issued to Medicare contractors based upon the November 1, 2007, Medicare Physician Fee Schedule (MPFS) Final Rule.
Background
The Social Security Act (Section 1848(c)(4); see http://www.ssa.gov/OP_Home/ssact/title18/1848.htm on the Internet) authorizes the Centers for Medicare & Medicaid Services (CMS) to establish ancillary policies necessary to implement relative values for physicians’ services. Previously, payment files were issued to Medicare contractors based upon the November 1, 2007, Medicare Physician Fee Schedule Final Rule.
Change Request (CR) 5902 amends those payment files.
In summary, CR 5902 instructs your Medicare contractor to:
- Manually update their systems to reflect 5 base units for Current Procedural Terminology (CPT) code 01916; and
- Manually update their Healthcare Common Procedure Coding System (HCPCS) file to include the laboratory certification code (LC) 400 for CPT code 89060 on or after January 1, 2008.
Note: See Attachment 1 of CR 5902 for a list of detailed changes for certain CPT/HCPCS codes included in the Emergency Update to the 2008 Medicare Physician Fee Schedule Database (MPFSDB). The Web address for accessing CR5902 is in the next section of this article.
Additional Information
The official instruction, CR 5902, issued to your Medicare carrier, FI, and A/B MAC regarding this change may be viewed at http://www.cms.hhs.gov/Transmittals/downloads/R1435CP.pdf on the CMS Web site.
If you have any questions, please contact your Medicare carrier, FI, or A/B MAC at their toll-free number, which may be found at
http://www.cms.hhs.gov/MLNProducts/downloads/CallCenterTollNumDirectory.zip on the CMS Web site.
News Flash – It’s Not Too Late to Give and Get the Flu Shot! In the U.S., the peak of flu season typically occurs anywhere from late December through March; however, flu season can last as late as May. Each office visit presents an opportunity for you to talk with your patients about the importance of getting an annual flu shot and a one time pneumococcal vaccination. Protect yourself, your patients, and your family and friends by getting and giving the flu shot. Don’t Get the Flu. Don’t Give the Flu. Get Vaccinated! Remember – Influenza and pneumococcal vaccinations and their administration are covered Part B benefits. Note that influenza and pneumococcal vaccines are NOT Part D covered drugs. You and your staff can learn more about Medicare’s coverage of adult immunizations and related provider education resources, by reviewing Special Edition MLN Matters article SE0748 at
http://www.cms.hhs.gov/MLNMattersArticles/downloads/SE0748.pdf on the CMS Web site.
Erythropoiesis Stimulating Agents (ESAs) in Cancer and Related Neoplastic Conditions
News Flash – Test Your Medicare Claims Now! After you have submitted claims containing both National Provider Identifiers (NPIs) and legacy identifiers and those claims have been paid, Medicare urges you to send a small batch of claims now with only the NPI in the primary provider fields. If the results are positive, begin increasing the number of claims in the batch. (Reminder: For institutional claims, the primary provider fields are the Billing and Pay-to Provider fields. For professional claims, the primary provider fields are the Billing, Pay-to, and Rendering Provider fields. If the Pay-to Provider is the same as the Billing Provider, the Pay-to Provider does not need to be identified.)
Provider Types Affected
Providers and suppliers who bill Medicare contractors (carriers, fiscal intermediaries (FI), Regional Home Health Intermediaries (RHHI), Medicare Administrative Contractors (A/B MAC) and Durable Medical Equipment Medicare Administrative Contractors (DME MAC)) for administering or supplying Erythropoiesis Stimulating Agents (ESAs) for cancer and related neoplastic conditions to Medicare beneficiaries.
What You Need to Know
Following a National Coverage Analysis (NCA) to evaluate the uses ESAs in non-renal disease applications, the Centers for Medicare & Medicaid Services (CMS), on July 30, 2007, issued a Decision Memorandum (DM) that addressed ESA use in non-renal disease applications (specifically in cancer and other neoplastic conditions).
CR 5818 communicates the NCA findings and the coverage policy in the National Coverage Determination (NCD). Specifically, CMS determines that ESA treatment is reasonable and necessary for anemia secondary to myelosuppressive anticancer chemotherapy in solid tumors, multiple myeloma, lymphoma, and lymphocytic leukemia under specified conditions; and not reasonable and necessary for beneficiaries with certain other clinical conditions, as listed below.
The HCPCS codes specific to non-end-stage renal disease (ESRD) ESA use are J0881 and J0885. Claims processed with dates of service July 30, 2007, through December 31, 2007, do not have to include the ESA modifiers as the modifiers are not effective until January 1, 2008. However, providers are to begin using the modifiers as of January 1, 2008, even though full implementation of related system edits are not effective until April 7, 2008.
Make sure that your billing staffs are aware of this guidance regarding ESA use.
Background
Emerging safety concerns (thrombosis, cardiovascular events, tumor progression, and reduced survival) derived from clinical trials in several cancer and non-cancer populations prompted CMS to review its coverage of ESAs. In so doing, on March 14, 2007, CMS opened an NCA to evaluate the uses of ESAs in non-renal disease applications, and on July 30, 2007, issued a DM specifically narrowed to the use of ESAs in cancer and other neoplastic conditions.
Reasonable and Necessary ESA Use
CMS has determined that ESA treatment for the anemia secondary to a regimen of myelosuppressive anticancer chemotherapy in solid tumors, multiple myeloma, lymphoma, and lymphocytic leukemia is reasonable and necessary only under the following specified conditions:
- The hemoglobin level immediately prior to the first administration is < 10 g/dL (or the hematocrit is < 30%) and the hemoglobin level prior to any maintenance administration is < 10g/dL (or the hematocrit is < 30%.);
- The starting dose for ESA treatment is up to either of the recommended Food and Drug Administration (FDA) approved label starting doses for cancer patients receiving chemotherapy, which includes the,150 U/kg/3 times weekly or the 40,000 U weekly doses for epoetin alfa and the 2.25 mcg/kg/weekly or the 500 mcg once every three week dose for darbepoetin alpha;
- Maintenance of ESA therapy is the starting dose if the hemoglobin level remains below 10 g/dL (or hematocrit is < 30%) 4 weeks after initiation of therapy and the rise in hemoglobin is > 1g/dL (hematocrit > 3%);
- For patients whose hemoglobin rises < 1 g/dl (hematocrit rise < 3%) compared to pretreatment baseline over 4 weeks of treatment and whose hemoglobin level remains < 10 g/dL after 4 weeks of treatment (or the hematocrit is < 30%), the recommended FDA label starting dose may be increased once by 25%. Continued use of the drug is not reasonable and necessary if the hemoglobin rises < 1 g/dl (hematocrit rise < 3%) compared to pretreatment baseline by 8 weeks of treatment;
- Continued administration of the drug is not reasonable and necessary if there is a rapid rise in hemoglobin > 1 g/dl (hematocrit > 3%) over any 2 week period of treatment unless the hemoglobin remains below or subsequently falls to < 10 g/dL (or the hematocrit is < 30%). Continuation and reinstitution of ESA therapy must include a dose reduction of 25% from the previously administered dose; and
- ESA treatment duration for each course of chemotherapy includes the 8 weeks following the final dose of myelosuppressive chemotherapy in a chemotherapy regimen.
Not Reasonable and Necessary ESA Use
Either because of a deleterious effect of ESAs on the underlying disease, or because the underlying disease increases the risk of adverse effects related to ESA use, CMS has also determined that ESA treatment is not reasonable and necessary for beneficiaries with the following clinical conditions:
- Any anemia in cancer or cancer treatment patients due to folate deficiency (diagnosis code 281.2), B-12 deficiency (281.1 or 281.3), iron deficiency (280.0-280.9), hemolysis (282.0, 282.2, 282.9, 283.0, 283.2, 283.9, 283.10, 283.19), bleeding (280.0 or 285.1), or bone marrow fibrosis;
- Anemia associated with the treatment of acute and chronic myelogenous leukemias (CML, AML) (205.00-205.21, 205.80-205.91), or erythroid cancers (207.00-207.81);
- Anemia of cancer not related to cancer treatment;
- Any anemia associated only with radiotherapy;
- Prophylactic use to prevent chemotherapy-induced anemia;
- Prophylactic use to reduce tumor hypoxia;
- Erythropoietin-type resistance due to neutralizing antibodies; and
- Anemia due to cancer treatment if patients have uncontrolled hypertension.
Claims Processing
Effective for claims with dates of service on or after January 1, 2008, Medicare will deny non-ESRD ESA services for J0881 or J0885 when:
- Billed with modifier EC (ESA, anemia, non-chemo/radio) when a diagnosis on the claim is present for any anemia in cancer or cancer treatment patients due to folate deficiency (diagnosis code 281.2), B-12 deficiency (281.1 or 281.3), iron deficiency (280.0-280.9), hemolysis (282.0, 282.2, 282.9, 283.0, 283.2, 283.9, 283.10, 283.19), bleeding (280.0 or 285.1), anemia associated with the treatment of acute and chronic myelogenous leukemias (CML, AML) (205.00-205.21, 205.80-205.91), or erythroid cancers (207.00-207.81).
- Billed with modifier EC for any anemia in cancer or cancer treatment patients due to bone marrow fibrosis, anemia of cancer not related to cancer treatment, prophylactic use to prevent cancer-induced anemia, prophylactic use to reduce tumor hypoxia, erythropoietin-type resistance due to neutralizing antibodies, and anemia due to cancer treatment if patients have uncontrolled hypertension.
- Billed with modifier EA (ESA, anemia, chemo-induced) for anemia secondary to myelosuppressive anticancer chemotherapy in solid tumors, multiple myeloma, lymphoma, and lymphocytic leukemia when a hemoglobin 10.0g/dL or greater or hematocrit 30.0% or greater is reported.
- Billed with modifier EB (ESA, anemia, radio-induced).
Note: Denial of claims for non-ESRD ESAs for cancer and related neoplastic indications as outlined in NCD 110.21 are based on reasonable and necessary determinations. A provider may have the beneficiary sign an Advance Beneficiary Notice (ABN), making the beneficiary liable for services not covered by Medicare. When denying ESA claims, contractors will use Medicare Summary Notice 15.20, The following policies [NCD 110.21] were used when we made this decision, and remittance reason code 50, These are non-covered services because this is not deemed a `medical necessity’ by the payer. However, standard systems shall assign liability for the denied charges to the provider unless documentation of the ABN is present on the claim. Denials are subject to appeal and standard systems shall allow for medical review override of denials. Contractors may reverse the denial if the review results in a determination of clinical necessity.
Medicare contractors have discretion to establish local coverage policies for those indications not included in NCD 110.21
Medicare Contractors shall not search files to retract payment for claims paid prior to April 7, 2008.
However, contractors shall adjust claims brought to their attention.
Additional Information
If you have any questions, please contact your Medicare contractor at their toll-free number, which may be found at http://www.cms.hhs.gov/MLNProducts/downloads/CallCenterTollNumDirectory.zip on the CMS Web site.
This addition/revision of section 110.21 of Pub.100-03 is an NCD. NCDs are binding on all carriers, FIs, quality improvement organizations, qualified independent contractors, the Medicare Appeals Council, and administrative law judges (ALJs) (see 42 CFR section 405.1060(a)(4) (2005)). An NCD that expands coverage is also binding on a Medicare advantage organization. In addition, an ALJ may not review an NCD. (See section 1869(f)(1)(A)(i) of the Social Security Act.)
The official instruction, CR5818, was issued to your contractor in two transmittals. The first is the NCD transmittal and that is available at http://www.cms.hhs.gov/Transmittals/downloads/R80NCD.pdf on the CMS Web site. The second transmittal revises the Medicare Claims Processing Manual and it is at http://www.cms.hhs.gov/Transmittals/downloads/R1413CP.pdf on the same site.
News Flash – It’s Not Too Late to Get the Flu Shot. We are in the midst of flu season and a flu vaccine is still the best way to prevent infection and the complications associated with the flu. But re-vaccination is necessary each year because flu viruses change each year. Please encourage your Medicare patients who haven’t already done so to get their annual flu shot. And don’t forget to immunize yourself and your staff. Protect yourself, your patients, and your family and friends. Get Your Flu Shot – Not the Flu! Remember Influenza vaccination is a covered Part B benefit. Note that influenza vaccine is NOT a Part D covered drug. Health care professionals and their staff can learn more about Medicare’s coverage of adult immunizations and related provider education resources, by reviewing Special Edition MLN Matters article SE0748 at
http://www.cms.hhs.gov/MLNMattersArticles/downloads/SE0748.pdf on the CMS Web site.
Extension of the Dates of Service Eligible for the Physician Scarcity Area (PSA) Bonus Payment
News Flash – It’s Not Too Late to Give and Get the Flu Shot! In the U.S., the peak of flu season typically occurs anywhere from late December through March; however, flu season can last as late as May. Each office visit presents an opportunity for you to talk with your patients about the importance of getting an annual flu shot and a one time pneumococcal vaccination. Protect yourself, your patients, and your family and friends by getting and giving the flu shot. Don’t Get the Flu. Don’t Give the Flu. Get Vaccinated! Remember – Influenza and pneumococcal vaccinations and their administration are covered Part B benefits. Note that influenza and pneumococcal vaccines are NOT Part D covered drugs. You and your staff can learn more about Medicare’s coverage of adult immunizations and related provider education resources, by reviewing Special Edition MLN Matters article SE0748 at
http://www.cms.hhs.gov/MLNMattersArticles/downloads/SE0748.pdf on the CMS Web site.
Provider Types Affected
Physicians, and other providers, who bill Medicare contractors (fiscal intermediaries (FI), carriers, or Medicare Administrative Contractors (A/B MAC)) for providing services to Medicare beneficiaries in designated physician scarcity areas.
What You Need to Know
CR 5937, from which this article is taken announces the extension of the physician scarcity area (PSA) bonus payment for dates of service through June 30, 2008. You should make sure that your billing staffs are aware of this PSA bonus payment extension.
Background
Section 413(a) of the Medicare Modernization Act of 2003 (MMA) required the Centers for Medicare & Medicaid Services (CMS) to pay a 5% bonus to physicians in a designated PSA for dates of service from January 1, 2005 through December 31, 2007. The Medicare, Medicaid, and State Children’s Health Insurance Program (SCHIP) Extension Act of 2007 amended Section 1833(u)(1) of the Social Security Act, extending the payment of the PSA bonus for dates of service through June 30, 2008. CR 5937, from which this article is taken, announces this extension and provides Medicare contractors with implementing instructions.
Medicare contractors will continue to pay PSA bonuses for dates of service from January 1, 2005 through June 30, 2008, regardless of whether the bonus is requested through submission of a modifier or made through an automated payment based on ZIP code. The primary care and specialty care scarcity areas in effect on December 31, 2007 will be used for 2008 services. Fiscal Intermediaries (FI) and Medicare Administrative Contractors (A/B MACs) processing Part A claims will implement this CR on January 7, 2008, and carriers and A/B MACs Processing Part B claims will implement it 30 days from issuance;
Carriers and A/B MACs processing Part B claims will Identify claims that contain the AR modifier (physician providing services in a PSA) and are submitted with dates of service on or after January 1, 2008 and processed prior to this CR’s implementation so that they may be included in the calculation in the first quarterly 2008 bonus payment. Additionally, when brought to their attention, carriers and A/B MACs processing Part B claims will re-open and re-process claims with these dates of service that are processed prior to the CR’s implementation date in order to include the AR modifier and make the appropriate bonus payment.
Additional Information
You can find the official instruction, CR 5937, issued to your FI, carrier, or A/B MAC by visiting
http://www.cms.hhs.gov/Transmittals/downloads/R1434CP.pdf on the CMS Web site. The updated Medicare Claims Processing Manual, Chapter 4 (Part B Hospital (Including Inpatient Hospital Part B and OPPS)), Sections 250.2.1 (Billing and Payment in a Physician Scarcity Area (PSA)) and 250.2.2 (Zip Code Files); and Medicare Claims Processing Manual, Chapter 12 (Physicians/Nonphysician Practitioners, Sections 90.5 (Billing and Payment in a Physician Scarcity Area (PSA)) and 90.5.2 (Identifying Physician Scarcity Area Locations) are attachments to that CR.
If you have any questions, please contact your FI, carrier, or A/B MAC at their toll-free number, which may be found at
http://www.cms.hhs.gov/MLNProducts/downloads/CallCenterTollNumDirectory.zip on the CMS Web site.
Health Care Provider Taxonomy Code Set
Under HIPAA, code sets that characterize a general administrative situation, rather than a medical condition or service, are referred to as non-clinical or non- medical code sets. The Provider Taxonomy code set is an external non-medical data code set designed for use in classifying health care providers according to provider type or practitioner specialty in an electronic environment, specifically within the American National Standards Institute (ANSI) Accredited Standards Committee (ASC) health care transaction.
The Health Care Provider Taxonomy Code (HPTC) is not required. However, if a HPTC is submitted it must be valid data from that code set. The HPTC is a named code set in the 837 professional implementation guide, thus carriers must validate the inbound taxonomy codes against their internal HPTC tables.
The HPTCs are updated twice per year, in April and October. The summary of changes is noted in the table below:
| TYPE OF CHANGE | PROVIDER TAXONOMY VALUE CODE |
| Additions | • 111NP0017X • 173C00000X • 173F00000X • 1835P0018X • 253J00000X |
| Revisions | • 207ND0101X • 207NS0135X • 2084A0401X • 2086X0206X • 2086S0127X |
The HPTC code list is available in two forms from the Washington Publishing Company:
http://www.wpc-edi.com/codes/taxonomy
- A free Adobe PDF download or
- An electronic representation of the list which will facilitate automatic loading of the code set. This version is available for purchase.
Implementation of the Medicare Clinical Laboratory Services Competitive Bidding Demonstration
News Flash – It’s Not Too Late to Give and Get the Flu Shot! In the U.S., the peak of flu season typically occurs anywhere from late December through March; however, flu season can last as late as May. Each office visit presents an opportunity for you to talk with your patients about the importance of getting an annual flu shot and a one time pneumococcal vaccination. Protect yourself, your patients, and your family and friends by getting and giving the flu shot. Don’t Get the Flu. Don’t Give the Flu. Get Vaccinated! Remember – Influenza and pneumococcal vaccinations and their administration are covered Part B benefits. Note that influenza and pneumococcal vaccines are NOT Part D covered drugs. You and your staff can learn more about Medicare’s coverage of adult immunizations and related provider education resources, by reviewing Special Edition MLN Matters article SE0748 at
http://www.cms.hhs.gov/MLNMattersArticles/downloads/SE0748.pdf on the CMS Web site.
Provider Types Affected
Providers or suppliers who bill Medicare contractors (carriers, fiscal intermediaries (FI), or Medicare Administrative Contractors (A/B MAC)) and/or order laboratory services for Medicare fee-for-service (FFS) beneficiaries under the Medicare Clinical Laboratory Services Competitive Bidding Demonstration project.
What you need to know
CR 5772, from which this article is taken, implements the Centers for Medicare & Medicaid Services (CMS) Medicare Clinical Laboratory Services Competitive Bidding Demonstration in the first Competitive Bidding Area (San Diego-Carlsbad-San Marcos, California metropolitan statistical area, or CBA1); and changes some of the demonstration’s requirements that were stated in CR5205, issued August 1, 2006, (see the MLN Matters article at
http://www.cms.hhs.gov/MLNMattersArticles/downloads/MM5205.pdf on the CMS Web site) and superceded by CR5359, issued November 1, 2006, (see the MLN Matters article at http://www.cms.hhs.gov/MLNMattersArticles/downloads/MM5359.pdf on the CMS Web site).
Specifically, CR5772 requires that:
- The demonstration covers tests provided to beneficiaries enrolled in the traditional fee-for-service (FFS) Medicare program who reside in the competitive bidding area (CBA1) during the 3-year demonstration period required bidders that do not bid, or bid and do not win, may serve as a reference laboratory to laboratories participating in the demonstration. However, they would not be allowed to bill Medicare directly for demonstration tests performed for Medicare FFS beneficiaries residing in the CBA.
- Laboratories not required to bid: These laboratories will be paid under the competitively set demonstration fee schedule for the duration of the demonstration.
- CMS will exempt laboratories that supply less than $100,000 annually in demonstration tests to Medicare FFS beneficiaries residing in the CBA from submitting bids.
- CMS will exempt laboratories providing services exclusively to beneficiaries entitled to Medicare by reason of end-stage renal disease (ESRD) from submitting bids. (Tests that are paid as part of the ESRD payment bundle are excluded from the demonstration.)
- CMS will exempt laboratories providing services exclusively to beneficiaries in nursing facilities or receiving home health services from submitting bids.
- CR5772 further announces that the demonstration in CBA1 is scheduled to begin on July 1, 2008; and provides Medicare contractors detailed record layouts for the quarterly report and for listing laboratories in the CBA.
- CMS will issue a later CR that implements the demonstration in the second CBA (CBA2), which is tentatively scheduled to start on July 1, 2009.
Background
Section 302(b) of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) requires CMS to conduct a project to demonstrate the application of competitive acquisition for the payment of most clinical laboratory services that would otherwise be payable under the Medicare Part B fee schedule.
In this project, each of two demonstration sites (competitive bidding areas – CBA1 and CBA2) will run for three years with a staggered start of one year. It will cover certain “demonstration tests” furnished under Medicare Part B to any beneficiary enrolled in FFS Medicare who lives in the CBAs. <
